Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective Analysis of patients that received shockwave lithotripsy as Treatment of ureteral or kidney Stones. Condition examinated is the effect of low molecular weight Heparins and acetylsalicylic acid on the Formation of renal hematoma after shockwave lithotripsy. Primary outcome is documented hematoma in a postoperative ultrasound control. Secondary outcomes are perioperative complication, Need for erythrocyte tranfusion, interventions for bleeding control, readmission or death within 30 days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

NCT02684812

Subarachnoid Hemorrhage

COMPLETED PHASE2/PHASE3

Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma

NCT03582293

Hematoma, Subdural, Chronic

RECRUITING PHASE3

Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.

NCT04367155

Renal Stones Nephrolithiasis

UNKNOWN NA

Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis

NCT04855877

Hemorrhage Postoperative Anterior Cruciate Ligament Rupture Arthroscopy +1 more

UNKNOWN PHASE4

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

NCT04555343

Urologic Diseases Prostate Cancer Bladder Cancer +5 more

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urolithiasis Renal Hematoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

No interventions assigned to this group

Acetylsalicylic acid

Patients that were on medication with Acetylsalicylic acid on the date of shockwave lithotripsy

Acetylsalicylic acid

Intervention Type DRUG

Low Molecular weight heparin

Patients that were on medication with low molecular heparin on the date of shockwave lithotripsy

low molecular weight heparin

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acetylsalicylic acid

Intervention Type DRUG

low molecular weight heparin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* consent
* Stones in kidney and proximal Ureter
* Treatment with shockwave lithotripsy for urolithiasis between January 2009 and September 2015 at Kantonsspital Winterthur